Images List Premium Download Classic

Adverse Event

Adverse Event-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Prognosis of adverse events in patients with suspected chronic heart failure
B.r.a.h.m.s. Gmbh
December 28, 2017 - N°20170370940

The present invention is in the field of clinical diagnostics. Particularly the present invention relates to the prognosis of adverse events in patients with stable chronic heart failure or being suspected of having stable chronic heart failure by determination of the level of procalcitonin (pct).
Closed-loop control of insulin infusion
Medicus Engineering Aps
December 28, 2017 - N°20170368258

Disclosed herein are devices, methods and systems for monitoring and detection of adverse events in a subject. In an embodiment, an insulin delivery device includes an insulin injection device in communication with a controller for controlling the insulin injection device. The controller is configured to receive a heart signal from one or more heart sensors, and a blood glucose signal ...
Bolus dose of hydroxycitric acid with glycerol
Glykon Technologies Group, Llc
December 28, 2017 - N°20170368008

A method of delivering a daily dose of hydroxycitric acid in the form of a salt as a single bolus that is as effective or more so than the same amount of active delivered via two or three administrations (b. I. D. Or t. I. D.) using current delivery modalities. The method reduces the rate of occurrence of common adverse ...
Adverse Event Patent Pack
Download + patent application PDFs
Adverse Event Patent Applications
Download + Adverse Event-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Adverse Event-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by cd3-specific binding domains
Amgen Research (munich) Gmbh
November 16, 2017 - N°20170327581

The present invention relates in essence to a compound which decreases or inhibits the binding of mammalian t-cells to mammalian endothelial cells for use in a method of prophylaxis and/or amelioration and/or treatment of clinical adverse events caused by therapy which comprises re-directing of t-cells against target cells in a patient. Methods of treatment of patients having or ...
Method, system and computer program product for managing health care risk exposure of an organization
Leantaas
October 26, 2017 - N°20170308829

Method, system and computer program product for facilitating management of health care risk exposure of an organization are disclosed. The method includes receiving a plurality of records associated with an organization from one or more data sources. Each record includes data corresponding to a health related adverse event. The data is received in a structured form. A set of composite ...
Materials and methods for improving the effectiveness of immunomodulatory cancer therapy and related methodologies
October 19, 2017 - N°20170298440

The disclosure provides methods of improving the effectiveness of an immunomodulatory cancer therapy by selecting a patient population amenable to immunomodulatory cancer therapy and methods of selecting cancer patient populations amenable to immunomodulatory therapy by measuring t cell repertoire clonality as well as methods of selecting cancer patients at reduced risk of developing an adverse event in response to such ...
Adverse Event Patent Pack
Download + patent application PDFs
Adverse Event Patent Applications
Download + Adverse Event-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Adverse Event-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and device for prediction and detection of adverse events in bedridden people
Reqbo Aps
August 31, 2017 - N°20170245799

Embodiments relates to a method and apparatus for risk stratification, monitoring, detection and prediction of adverse events in bedridden people. The method and apparatus can be used to prevent heath related conditions in people.
Hydrant monitoring system and method
Silversmith, Inc.
August 03, 2017 - N°20170216645

A device for detecting adverse events in a fire hydrant, the device comprising a housing configured to mount to an exterior of the fire hydrant, the housing having a surface in register with the exterior of the fire hydrant, the surface having an aperture therein, a cover enclosing the housing and mounted to the fire hydrant at the surface. The ...
Proximity awareness system for motor vehicles
Ridar Systems Llc
July 27, 2017 - N°20170213460

Various embodiments provide enhanced warnings of potential future adverse events (e. G., automobile crashes) by tracking the location and motion of multiple vehicles, and providing alerts or warnings to the drivers of such vehicles in the event that a risk of an adverse event is identified.
Seatbelt buckle system
July 20, 2017 - N°20170203715

A seatbelt buckle system for law enforcement use, wherein the female portion of the buckle is located at the end of a segment which is in a generally upright and readily-accessible position to assure the safe and expeditious restraint of an individual. The individual securing the occupant is advantageously less prone to adverse events such as unwanted contact with or ...
Pharmaceutical composition for preventing or treating skin rash
Dong-a University Research Foundation For Industry-academy Cooperation
July 20, 2017 - N°20170202917

Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.
Methods for predicting response to treatment
Interleukin Genetics, Inc.
July 13, 2017 - N°20170198350

The present invention provides stratification methods and kits to identify whether an individual having an inflammation-related disorder has genotype-specific differential expression of il-1, i. E., is a “high” or “low” producer of il-1, such that s/he can be provided an appropriate anti-inflammatory drug and at an appropriate dose. The stratification of ...
Predicting drug-drug interactions and specific adverse events
International Business Machines Corporation
June 22, 2017 - N°20170177803

The present invention provides methods, systems and devices for drug-drug interaction and adverse event analysis. Chemical structures for one or more pairs of drugs are obtained from at least one of a user and a database. A chemical fingerprint is generated for each drug of the one or more pairs of drugs based on the chemical structure of the drug. ...
Adverse Event Patent Pack
Download + patent application PDFs
Adverse Event Patent Applications
Download + Adverse Event-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Adverse Event-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Hospital operations system
Qwaltec, Llc
June 08, 2017 - N°20170161443

A hospital operations system is provided which centralizes, processes, prioritizes, and presents vast data generated by hospital systems and software applications and partially controls devices, alerts, and overall patient care within hospital systems for greater efficiency and provision of improved patient care, patient safety, and hospital efficiency beyond what currently exists. The hospital operations system capabilities are enabled via dedicated ...
Fail-safe lighting control system
June 01, 2017 - N°20170156189

A light fixture can include at least one light source, and at least one power supply that receives primary power, where the at least one power source generates final power using the primary power, where the at least one power supply delivers the final power to the at least one light source. The light fixture can also include a controller ...
Providing status of user devices during an adverse event
May 04, 2017 - N°20170127260

A method begins by an application server establishing information regarding a potentially adverse condition and determining group constraints for a group regarding the potentially adverse condition. The method continues with the application server selecting one or more user devices of a plurality of user devices affiliated with the group to produce selected user devices. The method continues with the application ...
Providing status of user devices during an adverse event
May 04, 2017 - N°20170127232

A method begins by a processing module identifying a geographic area of an adverse condition and identifying a user device of a plurality of user devices potentially associated with the identified geographic area. The method continues with the processing module issuing a safety notification to the user device, where the safety notification includes one or more of the identified geographic ...
Materials and methods for differential treatment of cancer
Serametrix Corporation
May 04, 2017 - N°20170121776

The present invention concerns differential therapeutic treatment of cancer patients based on prognostic antigen/antibody profiles used for predicting (prognosticating) a clinical response (efficacy) and/or adverse event to an immunotherapy for treatment of a malignancy in a subject, and for treating or delaying the onset or relapse of a malignancy in a subject.
Methods and systems for adverse event prediction using pump operating data
Heartware, Inc.
May 04, 2017 - N°20170119256

The present disclosure provides for each of a method of characterizing divergence of a monitored flow rate of blood through an implantable blood pump, and a method of predicting an upcoming adverse cardiac event using operating data of the blood pump, such as the characterized divergence data. Predicting an upcoming adverse cardiac event may be further based on similar operating ...
Prediction of adverse drug events
International Business Machines Corporation
April 27, 2017 - N°20170116390

Embodiments include method, systems and computer program products for predicting adverse drug events on a computational system. Aspects include receiving known drug data from drug databases and one or more of a candidate drug, a drug pair, and a candidate drug-patient pair. Aspects also include calculating an adverse event prediction rating representing a confidence level of an adverse drug event ...
Systems and methods for dynamically generated genomic decision support for individualized medical treatment
Aetna Inc.
April 27, 2017 - N°20170116379

Optimization of therapeutic outcomes is disclosed. By analyzing molecular genomic sequence data from an individual relative to a pre-defined knowledge base as well as dynamically generated analyses from comparison to a set of other individuals and molecular genomic sequence data of those other individuals along with their therapeutic history and clinical outcome, medication selection for optimum therapeutic outcomes is achieved. ...
Loading